Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Gerry MacQuillan"'
Autor:
William Kemp, Wendy Cheng, Katherine A. Stuart, Lauren Beswick, Amanda Nicoll, Richard Skoien, Siddharth Sood, Daniel Croagh, Hugh Gao, Andrew J. Metz, Ammar Majeed, Marie Sinclair, Eric Y. Lee, Avik Majumdar, Alexander J. Thompson, Simon Edmunds, Joanne Mitchell, Stuart K. Roberts, Nicholas Shackel, Kate Muller, Neomal S. Sandanayake, Alicia Braund, Martin Weltman, Philip I. Craig, Gerry MacQuillan, Edmund Tse, Stephen M. Riordan, Anouk Dev
Publikováno v:
Liver International. 41:2934-2943
BACKGROUND AND AIMS: IgG4 sclerosing cholangitis (IgG4-SC) is the biliary component of the multisystem IgG4-related disease. We aimed to investigate the clinical features, demographics, treatment response and outcomes of IgG4-SC in a large Australian
Autor:
Gerry MacQuillan, Tim Mitchell
Publikováno v:
Liver Transplantation. :334-343
Autor:
Paul J Gow, Joanne Mitchell, Simone I. Strasser, William Kemp, Ammar Majeed, Stuart K. Roberts, Jacob George, Geoffrey W. McCaughan, Jonathan Mitchell, Amanda Nicoll, Katherine A. Stuart, Gerry MacQuillan, Siddharth Sood
Publikováno v:
Scandinavian Journal of Gastroenterology. 55:1309-1317
As data is limited on the outcomes of calcineurin inhibitors (CNI) in autoimmune hepatitis (AIH), we evaluated the efficacy and safety of CNI in AIH patients who failed prior treatment(s).A retrospective study was performed of AIH patients who receiv
Autor:
Leon A. Adams, Jacob Ooi, David B. Preen, John Ferguson, Gary P. Jeffrey, Michael C. Wallace, Jonathan Tibballs, Gerry MacQuillan, Tiffany Khoo, Matthew Knuiman, George Garas, Shaun Samuelson
Publikováno v:
Journal of Gastroenterology and Hepatology. 35:1945-1952
BACKGROUND AND AIM Yttrium-90 resin microsphere radioembolization (RE) is not recommended for routine use in intermediate or advanced hepatocellular carcinoma (HCC) by recent guidelines. This study aims to establish pre-treatment variables which pred
Autor:
Yi Huang, Bastiaan de Boer, Briohny W. Smith, George Garas, Leon A. Adams, Zhengyi Wang, Gary P. Jeffrey, Michael C. Wallace, Luis Calzadilla Bertot, Gerry MacQuillan, John Joseph
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:2041-2049.e5
Background & Aims Metabolic dysfunction–associated fatty liver disease (MAFLD) is managed predominately in primary care, however, there is uncertainty regarding how to best identify patients for specialist referral. We examined the accuracy of noni
Autor:
Siddharth Sood, Ricky Lim, Geoffrey W. McCaughan, Wendy Cheng, Miriam T. Levy, Alan Wigg, William Sievert, Katherine A. Stuart, Simone I. Strasser, Gerry MacQuillan, Paul J Gow, Amanda Nicoll, Jonathan Mitchell, Edmund Tse, Stuart K. Roberts, Richard Skoien, Martin Weltman, Amany Zekry, Joanne Mitchell, Jacob George
Publikováno v:
Alimentary Pharmacology & Therapeutics. 49:1314-1322
BACKGROUND Mycophenolate mofetil is a commonly used salvage therapy for patients with autoimmune hepatitis (AIH). AIM To evaluate the predictors of response to mycophenolate rescue therapy to facilitate clinical decision making. METHODS We performed
Autor:
Navneet Ramlaul, Masood Iqbal, Ross Mac Nicholas, Diarmaid D. Houlihan, Leon A. Adams, Niamh Nolan, Jacob Ooi, George Garas, Gerry MacQuillan, P. Aiden McCormick, Gary P. Jeffrey
Publikováno v:
Liver Transplantation. 24:1622-1626
Publikováno v:
The American Journal of Case Reports
Patient: Female, 35-year-old Final Diagnosis: Fulminant liver failure Symptoms: Coagulopathy • hepatic encephalopathy • jaundice Medication:— Clinical Procedure: Liver transplantation Specialty: Gastroenterology and Hepatology Objective: Unusua
Autor:
Mazhar M Haque, K. New, Alan Wigg, Simone I. Strasser, Jacinta O'Keefe, Bruce McGarity, James O'Beirne, Ivan Valiozis, Miriam T. Levy, Mark Wilson, Zina Valaydon, Margaret Hellard, Rohit Sawhney, Scott Bowden, Martin Weltman, Emily Prewett, Gerry MacQuillan, Siddharth Sood, Timothy Papaluca, Edmund Tse, Mark W. Douglas, William Sievert, Leslie Fisher, Katherine A. Stuart, Gregory J. Dore, Alexander J. Thompson, Marie Sinclair, Amanda Wade, James Thomas, Jacob George, Golo Ahlenstiel, Simon Hazeldine, Joseph Doyle, Mark Stoove, Stuart K. Roberts, Aidan J. Woodward, Geoffrey C. Farrell
Publikováno v:
Clin Infect Dis
Background In clinical trials, hepatitis C virus (HCV) salvage treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) achieved an SVR12 rate of >95% in NS5A-experienced participants. Lower SVR12 rates have been reported in real-world studie
Autor:
Leon A. Adams, Yi Huang, John Joseph, Hans Nossent, Gerry MacQuillan, George Garas, Jonathan Chan, Zhengyi Wang, Wendy Cheng, Gary P. Jeffrey
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and aim Methotrexate (MTX) is routinely used for immunological disorders, and its long‐term use is associated with hepatotoxicity. The aim of this study was to investigate whether a serum liver fibrosis test (Hepascore) predicted the ris